Please use this identifier to cite or link to this item:
|Title:||Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.|
|Abstract:||The identification of anaplastic lymphoma kinase (ALK) rearrangements is found in approximately 5% of non-small-cell lung cancers (NSCLCs). However, the development of liquid biopsies as a diagnostic tool is less developed in these cases. This study investigates the use of CTCs during treatment, together with an extended follow-up to correlate with clinical evolution.|
|Appears in Collections:||Hospitales > H. U. Puerta de Hierro Majadahonda > Artículos|
Fundaciones e Institutos de Investigación > IIS H. U. Puerta de Hierro-Segovia de Arana > Artículos
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.